Navigation Links
NeurogesX, Inc. Announces $20 Million Private Placement
Date:7/22/2011

ct candidate, NGX-1998, is a topically applied liquid formulation containing a high concentration of capsaicin designed to treat pain associated with neuropathic pain conditions such as PHN. NGX-1998 has completed three Phase 1 clinical trials and patient enrollment has been completed in a Phase 2 clinical trial of NGX-1998 in PHN patients.

The Company's early-stage pipeline includes pre-clinical compounds which include a number of prodrugs of acetaminophen. The Company has evaluated certain of these compounds in vitro and in vivo.

Safe Harbor Statement

This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the Act). NeurogesX disclaims any intent or obligation to update these forward-looking statements, and claims the protection of the Safe Harbor for forward-looking statements contained in the Act. Examples of such statements include but are not limited to: statements regarding expectations regarding the submission of the supplemental new drug application for label expansion of Qutenza; the potential benefits of Qutenza and NGX-1998; expected proceeds and closing of the private placement; and the registration of any shares issued directly or indirectly in connection with the private placement.  Such statements are based on management's current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to: difficulties or delays in the further development of Qutenza for additional indications, including difficulties or delays in the submission of the sNDA for Qutenza; market acceptance of Qutenza in already approved indications may not be sufficient to support further pursuit of an expanded label for Qutenza, including as a result of physician or patient reluctance to use Qutenza; Qutenza and NeurogesX' other product candidates may have unexpected adverse side effects; potential a
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
2. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
3. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
4. Anesiva Announces Second Quarter 2008 Financial Results and Update
5. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
6. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
7. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
8. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. ThirdBiotech Announces Kemeta as Newest Sponsor
10. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
11. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2014)... Texas (PRWEB) August 31, 2014 ... the current state of the Epoxy Hardener ... a basic overview of the industry, including definitions, ... and Chinese domestic market analysis are provided with ... landscape of the market. A comparison between the ...
(Date:8/29/2014)... Albany, New York (PRWEB) August 29, 2014 ... Research “Global Orthobiologics Market” the global orthobiologics market was valued ... reach a market worth USD 5,519.9million in 2019at a CAGR ... the population aged 50 years and above is afflicted by ... almost double by the year 2020. This has and will ...
(Date:8/29/2014)... August 29, 2014 Due to a misstatement ... week, the Adult Stem Cell Technology Center, LLC ( ASCTC ... stem cell therapy research that might benefit ALS patients. ... for new stem cell technologies and therapeutic applications, FRC listed ... Bucket Challenge donors who wish not to support research ...
(Date:8/28/2014)... City, Ca. (PRWEB) August 28, 2014 ... E3 rating for an alcohol-based hand sanitizer, asks food ... harvest by comparing the hand sanitizer they’re currently using ... Spray . Hand hygiene is critical to fighting cross-contamination ... environment. Best Sanitizers believes there are key criteria ...
Breaking Biology Technology:Epoxy Hardener Industry Development Trends in Global & China Regions Now Available at ReportsnReports.com 2Epoxy Hardener Industry Development Trends in Global & China Regions Now Available at ReportsnReports.com 3Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 2Global Orthobiologics Market to Reach $5,519.9 Million by 2019: Transparency Market Research 3The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 2Food Processors and Food Handlers are Encouraged to Prepare for Fall Harvest by Evaluating Their Current Hand Sanitizer Using Nine Key Criteria 3
... ... Qteros of Marlborough, Mass., and Applied CleanTech, based in Israel, today ... from municipal and agricultural liquid waste into ethanol fuel for cars. ... feedstock has been found to boost ethanol production, address sewage sludge ...
... CryoLife, Inc., (NYSE: CRY ) ... today announced that it has received a Humanitarian Use Device ... its CryoValve® SG aortic human heart valve. The HUD ... Exemption (HDE) for the CryoValve SG aortic human heart valve, ...
... Calif., Oct. 6 Varian, Inc. (NasdaqGS: VARI) announced that at ... its stockholders adopted the merger agreement entered into with Agilent ... per share in cash. Approximately 84% of the shares ... the record date for the special meeting, voted to adopt ...
Cached Biology Technology:Cellulose from Wastewater Can Now be Turned into Fuel for Cars 2Cellulose from Wastewater Can Now be Turned into Fuel for Cars 3Cellulose from Wastewater Can Now be Turned into Fuel for Cars 4CryoLife Receives Humanitarian Use Device Designation for SynerGraft(R) Processed Human Aortic Heart Valves 2CryoLife Receives Humanitarian Use Device Designation for SynerGraft(R) Processed Human Aortic Heart Valves 3CryoLife Receives Humanitarian Use Device Designation for SynerGraft(R) Processed Human Aortic Heart Valves 4
(Date:9/1/2014)... CAMBRIDGE, Mass-- Conventional wisdom has long held that ... of coral reefs are passive organisms that ... substances, such as nutrients and oxygen. But now ... Science (WIS) in Israel have found that they ... sweep water into turbulent patterns that greatly enhance ...
(Date:9/1/2014)... nocturnal animals, bats are perfectly adapted to a life without ... the reflected echoes to measure distance to obstacles or prey. ... echo delays. A study carried out by researchers at Technische ... this map dynamically adapts to external factors. , ... flies in too close to an object, the number of ...
(Date:8/31/2014)... in modern medicine is developing drugs that are highly ... side-effects to the patient. Such properties are directly related ... the drug should have a shape that is perfectly ... it with high specificity. Publishing in Nature Chemistry ... that can impact the 3D structure of bioactive peptides ...
Breaking Biology News(10 mins):Nature's tiny engineers 2Nature's tiny engineers 3Zooming in for a safe flight 2A new synthetic amino acid for an emerging class of drugs 2A new synthetic amino acid for an emerging class of drugs 3
... VIRGINIA KEY, Fla. Seawater is a complex, ... materials that despite scientists best efforts, presents difficulties ... energy. Like the water itself, the calculations scientists ... revisions and clarifications over the years as research ...
... is available in Spanish . , TECNALIA ... multispectral artificial vision systems to enhance the value of electronic ... The aim of this project, known as SORMEN, is ... from electronic waste based on a system of multispectral vision ...
... part in protein folding to ensure cells function properly, ... with information critical to designing vaccines and helps them ... and Parkinson,s, that result from molecular motion gone awry. ... large computer clusters to run simulations. Or they had ...
Cached Biology News:New equation of state of seawater 2New equation of state of seawater 3TECNALIA uses artificial vision to improve recycling of electronic scrap metal 2TECNALIA uses artificial vision to improve recycling of electronic scrap metal 3TECNALIA uses artificial vision to improve recycling of electronic scrap metal 4New open-source software permits faster desktop computer simulations of molecular motion 2New open-source software permits faster desktop computer simulations of molecular motion 3
...
... is an evolutionarily conserved form of cell ... The central component of this process ... caspases. These enzymes participate in a ... response to pro-apoptotic signals and result in ...
... adapted Sf9 derivative for high-yield protein expression ... are derived from a high-yielding clone of ... serum-free TriEx Insect Cell Medium, these cells ... yields by either baculovirus infection or transfection ...
... antibody raised against a partial recombinant MAK. ... ~ 457 a.a) partial recombinant protein with GST ... Accession: BC039825 ... OMIM: 154235, GeneID: ...
Biology Products: